Skip to main content

Table 2 Comparative analysis between the studied groups as regard age, sex, and anthropometric measurements

From: Pentraxin-3 in non-alcoholic fatty liver disease and its affection by concomitant chronic hepatitis C infection

ParameterGroup (Mean ± SD)p value between three groupsp value between groups I and II
Group Ι
NAFLD patients (n = 25)
Group ΙΙ
NAFLD patients with HCV (n = 25)
Group ΙΙΙ
Healthy control (n = 20)
Age (in years)42.7 ± 11.243.3 ± 9.642.4 ± 6.90.920.83
Sex (freq. (%))Males11 (44.0)11 (44.0)8 (40.0)0.951.00
Females14 (56.0)14 (56.0)12 (60.0)
Body weight (Kg)94.8 ± 16.879.6 ± 10.169.7 ± 4.7< 0.001a< 0.001b
Height (cm)167.7 ± 8.9171.2 ± 9.8171.3 ± 3.20.250.17
Body mass index (Kg/m2)33.0 ± 5.126.7 ± 2.423.7 ± 1.6< 0.001a< 0.001b
Waist circumference (cm)110.8 ± 15.098.8 ± 9.583.9 ± 8.00.003a0.003b
  1. HCV hepatitis C virus, NAFLD nonalcoholic fatty liver disease
  2. aKruskal-Wallis test is statistically significant at 95% confidence level
  3. bMann-Whitney test is statistically significant at 95% confidence level